R&D Partner Content The Future of DDR-Targeted Oncology Starts Here! 9th DDR Inhibitors Summit | January 27–29, 2026 | Boston, MA
R&D Partner Content The Future of Patient-Centric Access is Here! 6th Operationalize: Expanded Access Programs Summit | March 24-26, 2026 | Boston, MA
R&D Partner Content 7th Annual AI in Drug Discovery Conference The 7th Annual AI in Drug Discovery Conference, hosted by SAE Media Group, takes place in March 2026
R&D Partner Content 6th Age-Related Disease Therapeutics Summit Translating Aging Science into a Clinical Reality
R&D Partner Content 7th CNS Drug Delivery Summit Unlocking Safer, More Efficient Delivery to Targeted Brain Regions by Advancing Direct, & Systemic Delivery to the CNS Via TfR1 & Beyond
R&D Partner Content Innovating Disease-Modifying Neurodegenerative Therapies to ... Discovering, Translating & Clinically Advancing Novel Targets
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
